These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20179939)

  • 41. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
    Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
    Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site.
    Fong D; Bhatia KS; Yeung D; King AD
    Oral Oncol; 2010 Aug; 46(8):603-6. PubMed ID: 20619723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
    Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy.
    Brenet E; Barbe C; Hoeffel C; Dubernard X; Merol JC; Fath L; Servagi-Vernat S; Labrousse M
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32422975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
    Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
    Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of intravoxel incoherent motion diffusion-weighted imaging in predicting early response to concurrent chemoradiotherapy in oesophageal squamous cell carcinoma.
    Li FP; Wang H; Hou J; Tang J; Lu Q; Wang LL; Yu XP
    Clin Radiol; 2018 Aug; 73(8):756.e17-756.e26. PubMed ID: 29731125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
    Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
    Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
    Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors.
    Iima M; Yamamoto A; Kataoka M; Yamada Y; Omori K; Feiweier T; Togashi K
    J Magn Reson Imaging; 2019 Jul; 50(1):88-95. PubMed ID: 30578563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer.
    Yuan Y; Pu H; Chen GW; Chen XL; Liu YS; Liu H; Wang K; Li H
    Eur Radiol; 2021 Jan; 31(1):200-211. PubMed ID: 32740816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma.
    Lombardi M; Cascone T; Guenzi E; Stecco A; Buemi F; Krengli M; Carriero A
    Radiol Med; 2017 May; 122(5):345-352. PubMed ID: 28188603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
    Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.
    Teng F; Aryal M; Lee J; Lee C; Shen X; Hawkins PG; Mierzwa M; Eisbruch A; Cao Y
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):969-977. PubMed ID: 29428251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.
    Lambrecht M; Van Calster B; Vandecaveye V; De Keyzer F; Roebben I; Hermans R; Nuyts S
    Radiother Oncol; 2014 Mar; 110(3):429-34. PubMed ID: 24630535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.